SamaGong, The mesencure mechanism appears valid
Post# of 148168
The mesencure mechanism appears valid, mesenchymal stem cells reducing inflammation (Mesoblast has demonstrated lesser results but in a larger, rigorous trial). These trial results are intriguing but not sufficient IMO.
There are many potential ways to approach reduction of innate immune dysregulation/disproportionate activation.
I don’t believe any are a match for Leronlimab.